Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul;48(6):759-779.
doi: 10.1097/MPA.0000000000001335.

Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer

Jami L Saloman, Kathryn M Albers, Zobeida Cruz-Monserrate  1 , Brian M Davis, Mouad Edderkaoui  2 , Guido Eibl  3 , Ariel Y Epouhe, Jeremy Y Gedeon, Fred S Gorelick, Paul J Grippo  4 , Guy E Groblewski  5 , Sohail Z Husain  6 , Keane K Y Lai, Stephen J Pandol  2 , Aliye Uc  7 , Li Wen  8 , David C Whitcomb  9
Affiliations
Review

Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer

Jami L Saloman et al. Pancreas. 2019 Jul.

Abstract

At the 2018 PancreasFest meeting, experts participating in basic research met to discuss the plethora of available animal models for studying exocrine pancreatic disease. In particular, the discussion focused on the challenges currently facing the field and potential solutions. That meeting culminated in this review, which describes the advantages and limitations of both common and infrequently used models of exocrine pancreatic disease, namely, pancreatitis and exocrine pancreatic cancer. The objective is to provide a comprehensive description of the available models but also to provide investigators with guidance in the application of these models to investigate both environmental and genetic contributions to exocrine pancreatic disease. The content covers both nongenic and genetically engineered models across multiple species (large and small). Recommendations for choosing the appropriate model as well as how to conduct and present results are provided.

PubMed Disclaimer

Conflict of interest statement

Disclosure

A.U. is a member of the American Board of Pediatrics, Subboard of Pediatric Gastroenterology; Associate Editor of Pancreatology; a consultant for Cystic Fibrosis Foundation. The rest of the authors declare no conflict of interest.

Figures

FIGURE 1.
FIGURE 1.
Questions that should be considered during study design when choosing an animal model.
See this image and copyright information in PMC

References

    1. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch A Pathol Anat Histol. 1977;373:97–117. - PubMed
    1. Watanabe O, Baccino FM, Steer ML, et al. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol. 1984;246:G457–G467. - PubMed
    1. Nathan JD, Patel AA, McVey DC, et al. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1322–1328. - PubMed
    1. Kaiser AM, Saluja AK, Sengupta A, et al. Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol. 1995;269:C1295–1304. - PubMed
    1. Klauss S, Schorn S, Teller S, et al. Genetically induced vs. classical animal models of chronic pancreatitis: a critical comparison. FASEB J. 2018;32:5778–5792. - PubMed

Publication types